Imaging of neuroendocrine neoplasms of the male GU tract

[1]  S. Faria,et al.  Imaging of Neuroendocrine Prostatic Carcinoma , 2021, Cancers.

[2]  J. Carrasquillo,et al.  Imaging of Pheochromocytoma and Paraganglioma , 2021, The Journal of Nuclear Medicine.

[3]  A. Colao,et al.  Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask , 2021, Frontiers in Endocrinology.

[4]  P. Ituarte,et al.  Natural History of Renal Neuroendocrine Neoplasms: A NET by Any Other Name? , 2021, Frontiers in Endocrinology.

[5]  A. D'Amico,et al.  NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[6]  Jiaoti Huang,et al.  Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms , 2021, Precision clinical medicine.

[7]  J. Epstein,et al.  Well Differentiated Neuroendocrine Tumors of Lower Urinary Tract: Biologic Behavior of a Rare Entity. , 2020, Human pathology.

[8]  X. Zu,et al.  Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms. , 2020, Clinical genitourinary cancer.

[9]  S. La Rosa,et al.  Classification of neuroendocrine neoplasms: lights and shadows , 2020, Reviews in Endocrine and Metabolic Disorders.

[10]  P. Bhosale,et al.  New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms , 2020, Abdominal Radiology.

[11]  S. Psutka,et al.  Small cell bladder cancer: Treatment patterns and clinical outcomes. , 2020 .

[12]  D. Cao,et al.  Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56. , 2020, Pathology, research and practice.

[13]  N. Lawrentschuk,et al.  Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study , 2020, The Lancet.

[14]  Jiaoti Huang,et al.  Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review. , 2020, Archives of pathology & laboratory medicine.

[15]  M. Lockhart,et al.  Imaging of scrotal masses , 2020, Abdominal Radiology.

[16]  J. Ro,et al.  Neuroendocrine tumors of genitourinary tract: Recent advances. , 2019, Annals of diagnostic pathology.

[17]  G. Patel,et al.  Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play , 2019, Cancers.

[18]  D. Klimstra,et al.  Classification of neuroendocrine neoplasms of the digestive system , 2019 .

[19]  S. Borges-Neto,et al.  Molecular Imaging and Therapy for Neuroendocrine Tumors , 2019, Current Treatment Options in Oncology.

[20]  O. Hamidi,et al.  Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management , 2019, Current opinion in endocrinology, diabetes, and obesity.

[21]  H. Saffar,et al.  The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis , 2019, International journal of hematology-oncology and stem cell research.

[22]  A. Elmgren,et al.  Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma , 2018, Journal of internal medicine.

[23]  K. Pacak,et al.  Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging , 2018, Front. Endocrinol..

[24]  M. Dietel,et al.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal , 2018, Modern Pathology.

[25]  Joshua M. Stuart,et al.  Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Maráz,et al.  The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract , 2018, AntiCancer Research.

[27]  S. Fine.  Neuroendocrine tumors of the prostate , 2018, Modern Pathology.

[28]  M. Yao,et al.  Large cell neuroendocrine carcinoma of the kidney with cardiac metastasis: a case report , 2017, Journal of Medical Case Reports.

[29]  A. Sidana,et al.  Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012). , 2017, Urologic oncology.

[30]  S. Usmani,et al.  Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer: 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT. , 2017, Clinical nuclear medicine.

[31]  K. Pacak,et al.  Relevant Discordance Between 68Ga-DOTATATE and 68Ga-DOTANOC in SDHB-Related Metastatic Paraganglioma: Is Affinity to Somatostatin Receptor 2 the Key? , 2017, Clinical nuclear medicine.

[32]  K. Duan,et al.  Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers , 2016, Cancer cytopathology.

[33]  R. Tothill,et al.  68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity , 2016, Cancer Imaging.

[34]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[35]  Liang Cheng,et al.  Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics , 2016, Endocrine Pathology.

[36]  T. Fojo,et al.  CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[37]  T. Kang,et al.  Carcinoid tumor associated with adjacent dysplastic columnar epithelium in the renal pelvis: A case report and literature review , 2016, Pathology international.

[38]  D. Heimann,et al.  Primary Neuroendocrine Tumor (Carcinoid Tumor) of the Testis: A Case Report with Review of Literature , 2015, The American journal of case reports.

[39]  J. Fallon,et al.  Distinct genetic alterations in small cell carcinoma from different anatomic sites , 2015, Experimental Hematology & Oncology.

[40]  Ximing J. Yang,et al.  Neuroendocrine differentiation of prostate cancer: a review. , 2014, American journal of clinical and experimental urology.

[41]  J. Epstein,et al.  Variant of prostatic adenocarcinoma with Paneth cell-like neuroendocrine differentiation readily misdiagnosed as Gleason pattern 5. , 2014, Human pathology.

[42]  M. Sharma,et al.  Ectopic insulin secreting neuroendocrine tumor of kidney with recurrent hypoglycemia: a diagnostic dilemma , 2014, BMC Endocrine Disorders.

[43]  H. Neumann,et al.  Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes , 2013, Clinical endocrinology.

[44]  M. Gumus,et al.  Primary renal carcinoid: treatment and prognosis. , 2013, Critical reviews in oncology/hematology.

[45]  M. Amin,et al.  Neuroendocrine carcinoma of the urinary bladder: a retrospective study of CT findings , 2013, Abdominal Imaging.

[46]  T. Dorff,et al.  Small cell bladder cancer: biology and management. , 2012, Seminars in oncology.

[47]  J. Donovan,et al.  Survival of patients with small cell carcinoma of the prostate during 1973–2003: a population‐based study , 2012, BJU international.

[48]  A. Parwani,et al.  Primary renal carcinoid tumors: clinicopathologic features of 9 cases with emphasis on novel immunohistochemical findings. , 2011, Human pathology.

[49]  D. Casalino,et al.  Paraganglioma of the bladder. , 2011, The Journal of urology.

[50]  K. Busam,et al.  An Immunohistochemical Study of Cervical Neuroendocrine Carcinomas: Neoplasms That are Commonly TTF1 Positive and Which May Express CK20 and P63 , 2010, The American journal of surgical pathology.

[51]  Tae Gu Kim,et al.  Primary small cell neuroendocrine carcinoma of the female urethra , 2009, Pathology international.

[52]  A. Lopez‐Beltran,et al.  Neuroendocrine tumours of the urinary system and male genital organs: clinical significance , 2009, BJU international.

[53]  G. Choe,et al.  Pictorial review: Unusual tumours involving the prostate: radiological-pathological findings. , 2008, The British journal of radiology.

[54]  C. Magi-Galluzzi,et al.  Renal neuroendocrine tumours: a clinicopathological study , 2007, BJU international.

[55]  J. Cheville,et al.  Renal Carcinoid Tumor: A Clinicopathologic Study of 21 Cases , 2007, The American journal of surgical pathology.

[56]  S. Fine.  Neuroendocrine Lesions of the Genitourinary Tract , 2007, Advances in anatomic pathology.

[57]  T. Jarrett,et al.  Primary carcinoid tumors of the kidney. , 2006, The Journal of urology.

[58]  A. Evans,et al.  Large Cell Neuroendocrine Carcinoma of Prostate: A Clinicopathologic Summary of 7 Cases of a Rare Manifestation of Advanced Prostate Cancer , 2006, The American journal of surgical pathology.

[59]  S. Dahrouge,et al.  Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center , 2006, BJU international.

[60]  P. Dahm,et al.  Malignant non-urothelial neoplasms of the urinary bladder: a review. , 2003, European urology.

[61]  S. Suster,et al.  Neuroendocrine carcinomas (carcinoid tumor) of the testis. A clinicopathologic and immunohistochemical study of ten cases. , 2003, American journal of clinical pathology.

[62]  Rocío Martín,et al.  Stereologic Estimation of the Number of Neuroendocrine Cells in Normal Human Prostate Detected by Immunohistochemistry , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[63]  Ximing J. Yang,et al.  Small Cell Carcinoma of the Urinary Bladder , 2000, European Urology.

[64]  Dietel,et al.  Expression of thyroid transcription factor‐1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites , 2000, Histopathology.

[65]  L. McWilliam,et al.  Neuroendocrine differentiation and prognosis in prostatic adenocarcinoma. , 1997, British journal of urology.

[66]  T. H. van der Kwast,et al.  The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long‐term follow‐up study with patients treated by radical prostatectomy , 1995, International journal of cancer.

[67]  M. Amin,et al.  Primary carcinoid tumor of testis. Immunohistochemical, ultrastructural, and DNA flow cytometric study of three cases with a review of the literature , 1993, Cancer.

[68]  B. Czerniak,et al.  TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate. , 2011, Human pathology.

[69]  E. van Marck,et al.  Small-cell carcinoma of the penile urethra: a case report and a short review of the literature. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  R. DeLellis.  Pathology and genetics of tumours of endocrine organs , 2004 .

[71]  H. Bonkhoff.  Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[72]  M. Wilkins.  Biology and Management , 1998 .